AKT and ERK1/2 signaling pathways have been reported to be involved in PKM2 nuclear translocation [32, 33], and were activated by ENO2 in HNSCC cells (Fig. 2a and e). The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.